Beclomethasone Dipropionate and Oropharyngeal Candidiasis
- 28 September 1974
- Vol. 3 (5934), 797-798
- https://doi.org/10.1136/bmj.3.5934.797
Abstract
A survey of 936 patients attending a respiratory diseases unit outpatient department was performed to assess the incidence of oropharyngeal candidiasis in patients inhaling beclomethasone dipropionate in daily doses of 400 μg or less. Throat swabs from 209 (41%) patients treated with beclomethasone were positive on culture for yeasts compared with positive swabs from 77 (27·2%) patients not receiving corticosteroid therapy either orally or by inhalation. Clinical oropharyngeal thrush, confirmed by culture, was detected in 28 (5·5%) patients inhaling beclomethasone, one (0·7%) patient receiving treatment with oral prednisolone, and two (0·7%) patients not being treated with corticosteroids.Keywords
This publication has 5 references indexed in Scilit:
- Steroid Aerosols in Asthma: An Assessment of Betamethasone Valerate and a 12-month Study of Patients on Maintenance TreatmentBMJ, 1974
- A controlled trial of beclomethasone dipropionate for asthmaRespiratory Medicine, 1973
- Beclomethasone Dipropionate Steroid Aerosol in Treatment of Perennial Allergic Asthma in ChildrenBMJ, 1973
- Beclomethasone dipropionate by inhalation in the treatment of airways obstruction.1972
- Incidence of candida in hospital in-patients and the effects of antibiotic therapy.BMJ, 1966